Selection of optimal combinations of target genes for therapeutic multi-gene silencing based on miRNA co-regulation.

about

Progression of mouse skin carcinogenesis is associated with the orchestrated deregulation of mir-200 family members, mir-205 and their common targets.A Vesicular Stomatitis Virus-Inspired DNA Nanocomplex for Ovarian Cancer Therapy.

P2860

Q38295568-029F11E4-BB4F-4DFC-A2BB-29333CE8C743 Q52624302-23765642-5A31-4A16-82B3-D3643F20EEE0

P2860

Selection of optimal combinations of target genes for therapeutic multi-gene silencing based on miRNA co-regulation.

Item

http://www.wikidata.org/entity/Q45887067

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Selection of optimal combinati ...... based on miRNA co-regulation.

@en

Selection of optimal combinati ...... based on miRNA co-regulation.

@nl

type

Item

label

Selection of optimal combinati ...... based on miRNA co-regulation.

@en

Selection of optimal combinati ...... based on miRNA co-regulation.

@nl

prefLabel

Selection of optimal combinati ...... based on miRNA co-regulation.

@en

Selection of optimal combinati ...... based on miRNA co-regulation.

@nl

P1476

Selection of optimal combinati ...... based on miRNA co-regulation.

@en

P2093

A Malek

http://www.w3.org/2001/XMLSchema#string

B Gyorffy

http://www.w3.org/2001/XMLSchema#string

C V Catapano

http://www.w3.org/2001/XMLSchema#string

R Schäfer

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of diverse regulatory networks in a hierarchical context shows consistent tendencies for collaboration in the middle levels.

A novel computational framework for simultaneous integration of multiple types of genomic data to identify microRNA-gene regulatory modules

Combining targeted therapies: practical issues to consider at the bench and bedside.

Dual targeting of EphA2 and FAK in ovarian carcinoma.

More is less -- combining targeted therapies in metastatic colorectal cancer.

Target genes suitable for silencing approaches and protein product interference in ovarian epithelial cancer.

RNA interference targeting human FAK and EGFR suppresses human non-small-cell lung cancer xenograft growth in nude mice.

HMGA2 gene is a promising target for ovarian cancer silencing therapy.

P2888

cgt.2013.20

P304

326-329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CGT.2013.20

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236338085

http://www.w3.org/2001/XMLSchema#string

P6179

1024436839

http://www.w3.org/2001/XMLSchema#string

P698

23618947

http://www.w3.org/2001/XMLSchema#string

Selection of optimal combinations of target genes for therapeutic multi-gene silencing based on miRNA co-regulation.

about

P2860

P2860

Selection of optimal combinations of target genes for therapeutic multi-gene silencing based on miRNA co-regulation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698